These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 182607)

  • 1. Incorporation of 75Se-selenomethionine into human apoproteins. III. Kinetic behavior of isotopically labeled plasma apoprotein in man.
    Eaton RP; Crespin S; Kipnis DM
    Diabetes; 1976 Aug; 25(8):679-90. PubMed ID: 182607
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Incorporation of 75Se-selenomethionine into human apoproteins. II. Characterization of metabolism of very-low-density and low-density lipoproteins in vivo and in vitro.
    Eaton RP; Crespin S; Kipnis DM
    Diabetes; 1976 Jan; 25(1):44-50. PubMed ID: 173606
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Incorporation of 75Se-selenomethionine into human apoproteins. I. Characterization of specificity in very-low-density and low-density lipoproteins.
    Eaton RP
    Diabetes; 1976 Jan; 25(1):32-43. PubMed ID: 173605
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 75Se-selenomethionine-labeled lipoproteins in hyperlipidemic and normolipidemic humans.
    Stähelin HB
    Metabolism; 1975 Apr; 24(4):505-15. PubMed ID: 163949
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Catabolism of very low density lipoprotein B apoprotein in man.
    Reardon MF; Fidge NH; Nestel PJ
    J Clin Invest; 1978 Mar; 61(3):850-60. PubMed ID: 205554
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evidence for the identity of the major apoprotein in low density and very low density lipoproteins in normal subjects and patients with familial hyperlipoproteinemia.
    Gotto AM; Brown WV; Levy RI; Birnbaumer ME; Fredrickson DS
    J Clin Invest; 1972 Jun; 51(6):1486-94. PubMed ID: 4336942
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Overproduction of a kinetic subclass of VLDL-apoB, and direct catabolism of VLDL-apoB in human endogenous hypertriglyceridemia: an analytical model solution of tracer data.
    Eaton RP; Allen RC; Schade DS
    J Lipid Res; 1983 Oct; 24(10):1291-303. PubMed ID: 6644179
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Observations on the passage of apoproteins from plasma lipoproteins into peripheral lymph in two men.
    Reichl D; Postiglione A; Myant NB; Pflug JJ; Press M
    Clin Sci Mol Med; 1975 Nov; 49(5):419-26. PubMed ID: 172278
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Preliminary model for human lipoprotein metabolism in hyperlipoproteinemia.
    Phair RD; Hammond MG; Bowden JA; Fried M; Fisher WR; Berman M
    Fed Proc; 1975 Dec; 34(13):2263-70. PubMed ID: 172373
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lipoproteins in atherosclerotic lesions. Localization by immunofluorescence of apo-low density lipoproteins in human atherosclerotic arteries from normal and hyperlipoproteinemics.
    Hoff HF; Titus JL; Bajardo RJ; Jackson RL; Gotto AM; DeBakey ME; Lie JT
    Arch Pathol; 1975 May; 99(5):253-8. PubMed ID: 165805
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The passage of apoproteins from plasma lipoproteins into the lipoproteins of peripheral lymph in man.
    Reichl D; Myant NB; Pflug JJ; Rudra DN
    Clin Sci Mol Med; 1977 Sep; 53(3):221-6. PubMed ID: 199396
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Significance of low density lipoprotein production in the regulations of plasma cholesterol level in man.
    Kesaniemi YA; Grundy SM
    J Clin Invest; 1982 Jul; 70(1):13-22. PubMed ID: 7085881
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Low density lipoprotein metabolism in a family of familial hypercholesterolemic patients.
    Packard CJ; Third JL; Shepherd J; Lorimer AR; Morgan HG; Lawrie TD
    Metabolism; 1976 Sep; 25(9):995-1006. PubMed ID: 183085
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Metabolic heterogeneity of low density lipoprotein-apoB production in familial hypercholesterolemia: an analytical model solution of tracer data.
    Eaton RP; Allen RC; Schade DS
    J Lipid Res; 1982 Jul; 23(5):738-46. PubMed ID: 7119572
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Metabolic studies in familial hypercholesterolemia. Evidence for a gene-dosage effect in vivo.
    Bilheimer DW; Stone NJ; Grundy SM
    J Clin Invest; 1979 Aug; 64(2):524-33. PubMed ID: 222811
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Metabolism of apoprotein B of plasma very low density lipoproteins in the rat.
    Faergeman O; Sata T; Kane JP; Havel RJ
    J Clin Invest; 1975 Dec; 56(6):1396-1403. PubMed ID: 172530
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characterization of the plasma lipoproteins of the genetically obese hyperlipoproteinemic Zucker fatty rat.
    Schonfeld G; Felski C; Howald MA
    J Lipid Res; 1974 Sep; 15(5):457-64. PubMed ID: 4369852
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Metabolism of lipoproteins in nonhuman primates. Studies on the origin of low density lipoprotein apoprotein in the plasma of the squirrel monkey.
    Illingworth DR
    Biochim Biophys Acta; 1975 Apr; 388(1):38-51. PubMed ID: 164942
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The metabolic fate of plasma lipoproteins in normal subjects and in patients with insulin resistance and endogenous hypertriglyceridaemia.
    Kissebah AH; Alfarsi S; Adams PW; Wynn V
    Diabetologia; 1976 Oct; 12(5):501-9. PubMed ID: 185113
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of ciprofibrate on LDL metabolism in man.
    Gaw A; Packard CJ; Caslake MJ; Griffin BA; Lindsay GM; Thomson J; Vallance BD; Wosornu D; Shepherd J
    Atherosclerosis; 1994 Aug; 108(2):137-48. PubMed ID: 7980713
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.